Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2001;32:2351-2355
doi: 10.1161/hs1001.096007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilbert, P.
Right arrow Articles by Thorin, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilbert, P.
Right arrow Articles by Thorin, E.
Related Collections
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Brain Circulation and Metabolism

(Stroke. 2001;32:2351.)
© 2001 American Heart Association, Inc.


Original Contributions

Endothelium-Derived Endothelin-1 Reduces Cerebral Artery Sensitivity to Nitric Oxide by a Protein Kinase C–Independent Pathway

Patricia Gilbert, BSc; Johanne Tremblay, PhD Eric Thorin, PhD

From Institut de cardiologie de Montréal, Centre de Recherche (P.G., E.T.), and Centre de Recherche de l’Hôtel-Dieu de Montréal, Montréal, Québec, Canada (J.T.).

Correspondence to Eric Thorin, PhD, Institut de cardiologie de Montréal, 500 rue Bélanger Est, Montréal, Québec, H1T 1C8 Canada.

Background and Purpose— Nitric oxide (NO) reduces endothelin-1 (ET-1) production and blunts ET-1 dependent vasoconstriction. The direct effects of smooth muscle ETA receptor stimulation on NO-mediated relaxation are unknown. We hypothesized that endothelium-derived ET-1 regulates vascular tone by reducing smooth muscle sensitivity to NO, possibly through activation of protein kinase C (PKC).

Methods— Rings of rabbit middle cerebral artery were mounted on microvessel myographs to measure isometric tension. Dose-response curves to acetylcholine (ACh) and sodium nitroprusside (SNP; an NO donor) were obtained with or without ET-1 receptor blockade. Experiments were performed in the presence of indomethacin (10 µmol/L). Results are expressed as mean±SEM.

Results— In depolarized conditions (40 mmol/L KCl physiological solution), ACh-induced relaxation was entirely NO-dependent, as indicated by its suppression by N{omega}-nitro-L-arginine (P<0.05). Arterial sensitivity (pD2) to ACh (6.32±0.11, n=6) was increased (P<0.05) to 6.77±0.10 (n=6) by BQ123 (ETA receptor antagonist, 5 µmol/L) but not by BQ788 (ETB receptor antagonist, 5 µmol/L; 6.08±0.22, n=5). Consistent with this finding, blockade of ETA receptors increased (P<0.05) vascular sensitivity to SNP (6.95±0.10, n=8), whereas BQ788 had no influence on arterial sensitivity to SNP (6.17±0.07, n=7) compared with control (6.43±0.13, n=11). In denuded arteries, the sensitivity to SNP (7.10±0.08, n=8) was reduced by exogenous ET-1 (6.51±0.35, n=7, P<0.05). Chelerythrine, a PKC inhibitor, did not alter smooth muscle sensitivity to NO, whereas phorbol 12-myristate 13-acetate, a PKC activator, strongly increased it.

Conclusions— Blockade of ETA but not ETB receptors sensitizes vascular smooth muscle to exogenous and endothelium-derived NO. This suggests that ET-1 regulates smooth muscle sensitivity to NO by a PKC-independent pathway. This represents an alternative pathway by which NO and ET-1 interact to regulate vascular tone.


Key Words: acetylcholine • cerebral vessels • endothelins • endothelium, vascular • nitrates • nitric oxide




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. H. Rosa Jr., T. W. Hein, Z. Yuan, W. Xu, M. I. Pechal, R. L. Geraets, J. M. Newman, and L. Kuo
Brimonidine evokes heterogeneous vasomotor response of retinal arterioles: diminished nitric oxide-mediated vasodilation when size goes small
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H231 - H238.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Migneault, S. Sauvageau, L. Villeneuve, E. Thorin, A. Fournier, N. Leblanc, and J. Dupuis
Chronically Elevated Endothelin Levels Reduce Pulmonary Vascular Reactivity to Nitric Oxide
Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 506 - 513.
[Abstract] [Full Text] [PDF]